Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Endothelial Function in Sleep Apnea
NCT04161339Phase 4Unknown
- Sponsor
- Instituto de Cardiologia do Rio Grande do Sul
- Start
- Jul 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in endothelial dysfunction comparing Hydroxychloroquine with Placebo (2 arms). Primary endpoints: Reactive Hyperemia Index at 8 weeks and Flow-Mediated Dilation at 8 weeks. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NCT04161339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04161339.